Amanda Cherpak, Senior Director of Product Management for Radiation Oncology Solutions at Varian, shared on LinkedIn:
“The day has come to share this with the world and the reception has been nothing short of amazing.
The conversations around Accela and NeoArc at ASTRO 2026 have been incredible. Radiotherapy already plays a critical role in cancer care, and the need for it continues to grow. That makes every minute in the clinic matter.
Accela brings imaging, planning, motion management, and treatment delivery together in ways designed to help care teams make better use of that time and ultimately help more patients get the care they need.
There’s a lot more ahead. It’s pretty incredible to be here for the beginning of it.
510(k) pending. Not available for sale and no guarantee of commercialization or feature availability.”
James Kavanaugh, Assistant Professor of Medical Physics and Division Chair of Medical Physics in the Department of Radiation Oncology at Mayo Clinic, Rochester, Minnesota, added:
“In our professional lives we might get 1 opportunity to really advance the field in a meaningful way. To fully leverage those opportunities requires a focused, dedicated team working collaboratively towards a common goal.
What the Accela Advisory Group has accomplished over the last 2+ years is a testament to the power of collaboration and the convergence of opportunity with an unrelenting desire to improve patient care.
I couldn’t be prouder of not only my Mayo Clinic colleagues but the teams from Washington University in St. Louis, Universitätsspital Zürich, Memorial Sloan Kettering Cancer Center, University Hospitals, Maastro – Instituut voor radiotherapie en oncologisch onderzoek, and Mass General Brigham, and the incredible accomplishments they have achieved.
Teams of more than 100 Medical Physicists, Dosimetrists, Radiation Oncologists, and Radiation Therapists have dedicated over 20,000 hours to evaluate and characterize the Accela and EclipseNeo systems.
Our combined efforts will result in more than 50 publications submitted in the next few months, softening the learning curve for those who will be installing this technology in their clinics.”
Lan H. Nguyen, Director of Product Marketing, Radiation Oncology Solutions at Varian, a Siemens Healthineers company, added:
“There’s something pretty special about seeing something so many people have worked toward for years finally take the stage.
Accela and NeoArc are officially here at ASTRO2026.
There’s a lot of incredible technology behind this moment, but at the heart of it is something incredibly simple: time.
Time for care teams to spend less of their day navigating complexity. Time for clinics to rethink what’s possible for the patients they serve. And most importantly, time patients can spend getting back to their lives.
The technology is remarkable. What it can mean for people matters even more.
This moment represents years of work across our teams and a shared belief that we can keep pushing radiation oncology forward while making the experience better for the people at the center of it.
Very proud to see Accela out in the world. And even prouder of the people who got it here.
510(k) pending. Not available for sale and no guarantee of commercialization or feature availability.”
